Evidence map›Paper›PMID 41273459›Full record

ArticleHealth economics review2025

Does price disclosure promote competition in private MRI markets? A difference-in-differences analysis.

Riina Hiltunen

Abstract read
In one paragraph

Article in Health economics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Riina HiltunenSocial Insurance Institution, Helsinki, Finland. riina.hiltunen@kela.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Finland’s private health care markets, a lack of price transparency has made price shopping difficult for consumers in the past. To address this issue, two distinct online price comparison tools were introduced. Economic theory and empirical research suggest that increasing price transparency can lower prices, but the impact depends on market conditions and the design of price disclosure. This paper examines the effect of these two distinct price disclosures on the prices of private magnetic resonance imaging (MRI) in Finland.

methodsWe utilize comprehensive administrative data from the National Health Insurance of Finland, which include all reimbursed procedures and prices in the private sector from 2008 to 2017. We employ a difference-in-differences approach to estimate the causal effects of price disclosures. Additionally, we use a market concentration index to control for the ex ante level of competition and explore whether market concentration is associated with the price effects.

resultsWe found that only the second price disclosure reduced MRI prices, with provider prices lowering by 5.2% and market prices by 10.6% relative to those of the control group. The effects varied across regions and time: the provider price effect became statistically insignificant after a year, whereas market prices reached a statistically significant reduction of 12% until the end of the study period. The effect was also stronger for concentrated markets, suggesting that price transparency inhibits companies’ ability to exert monopoly power.

conclusionsThe results align with those of previous studies, indicating that competition can be promoted through price transparency and that information disclosure is more effective when baseline market performance is low. As MRI services are highly standardized, it is unlikely that providers lower prices by compromising quality. However, a definitive conclusion on consumer welfare gains cannot be drawn. The different effects of the two price disclosures highlight the importance of design and market conditions in promoting competition and gaining savings. The first price disclosure failed, as it did not reveal the relevant price information sufficiently, and ex ante market conditions lowered the price sensitivity of both the consumers and providers.

Indexed as

Magnetic resonance imaging (MRI)Market competitionPrice comparison toolsPrice disclosure effectsPrice transparencyPrivate health care markets

Identifiers

PMID41273459
PMCPMC12809894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.